Faculty profile

Marie-France Savard

ResearcherUniversity of Ottawa

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Ottawa directory, so their courses may be missing. Find their university profile.

Marie-France Savard

Researcher

Health Sciences

University of Ottawa

Ottawa, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
24 publications in the last five years, latest in 2026.
Senior (last) author on 3 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Ottawa profile.

Breast Cancer Endocrine Therapy Older Patients Optimization Pragmatic Randomized Controlled Trial Adjuvant Endocrine Therapy Low-Risk Breast Cancer

Latest papers

Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast Cancer.
2026
Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study
Journal of Medical Internet Research · 2026
A Randomized Trial Evaluating Personalized Versus Guideline-Based Well Follow-Up Strategies for Patients with Early Breast Cancer: Feasibility Outcomes
Current Oncology · 2026

All 28 publications

Latest funding

A pragmatic, multicenter randomized study evaluating the benefits and risks of adjuvant endocrine therapy in patients aged 70 years or older with low-risk breast cancer (REaCT-70 Study).
CIHR · 2025 · Nominated PI
$25,000
A pragmatic, multicenter randomized study evaluating the benefits and risks of adjuvant endocrine therapy in patients aged 70 years or older with low-risk breast cancer (REaCT-70 Study).
CIHR · 2025 · Nominated PI
$600,000
The ESCAPE clinical trial of circulating tumor DNA to guide adjuvant therapy in chemo-resistant triple negative breast cancer
CIHR · 2023 · Co-investigator
$100,000

All 3 grants and awards

28 publications.

Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast Cancer.

Clemons M, Stober C, Pond GR, Conter H, Simos D, Dhesy-Thind S, Mates M, Trinkaus M, Hilton J, Savard M-F

20261 citations

DOI: 10.1056/evidoa2500202

Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study

Pilgram L, Yang K, Beltran-Bless A-A, Pond GR, Vandermeer L, Hilton J, Savard M-F, LeBlanc A, Shepherd L, Chen B

Journal of Medical Internet Research20261 citations

DOI: 10.2196/88665

A Randomized Trial Evaluating Personalized Versus Guideline-Based Well Follow-Up Strategies for Patients with Early Breast Cancer: Feasibility Outcomes

Beltran-Bless A-A, Himmelman E, Kim A, Pond GR, Fallah P, Ng T, Hilton J, Savard M-F, Larocque G, Baines K-A

Current Oncology2026

DOI: 10.3390/curroncol33040224

HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination With Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer.

Dieras V, Curigliano G, Martin M, Lerebours F, Tsurutani J, Savard MF, Jerzak KJ, Hu X, Martins de Aquino Pimentel LC, O'Sullivan CC, Tokunaga E, Okines A, Huang CS, Jacot W, Sohn J, Cronemberger Silva E, Mueller V, Yang S, Granata G, Shen Q, Santarpia L, Hamilton E, HER2CLIMB-05 Investigators

Journal of clinical oncology : official journal of the American Society of Clinical Oncology2026

DOI: 10.1200/jco-25-02600 PMID: 41369677

Summary of Research: HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer.

Dieras V, Curigliano G, Martin M, Lerebours F, Tsurutani J, Savard MF, Jerzak KJ, Hu X, O'Sullivan CC, Tokunaga E, Okines A, Huang CS, Jacot W, Sohn J, Cronemberger Silva E, Mueller V, Yang S, Granata G, Shen Q, Hamilton E, HER2CLIMB-05 Investigators

Targeted oncology2026

DOI: 10.1007/s11523-026-01245-w PMID: 42762393

Cardiovascular Disease in Males With Breast Cancer: A Population-Based Cohort Study.

Chauhan A, Giannakeas V, Thiruchelvam D, Thavendiranathan P, Amir E, Nadler MB, Savard MF, Abdel-Qadir H

JACC. Advances2026

DOI: 10.1016/j.jacadv.2026.102937 PMID: 42489382

Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study

Kababji SE, Mitsakakis N, Jonker E, Beltran-Bless A-A, Pond G, Vandermeer L, Radhakrishnan D, Mosquera L, Paterson A, Shepherd L

Journal of Medical Internet Research202515 citations

DOI: 10.2196/66821

Do regularly scheduled visits result in earlier detection of curable breast cancer recurrences?

Beltran-Bless A-A, de Lima Machada I, Clemons L, Pond GR, Bradbury M, Baines K-A, Larocque G, Vandermeer L, Savard M-F, Hilton J

Breast Cancer Research and Treatment20252 citations

DOI: 10.1007/s10549-025-07793-5

Patient perceptions around the use of clinico-pathologic and genomic tools in the management of early breast cancer

Beltran-Bless A-A, Saunders D, Clemons L, Machado I, Pond G, Hutton B, El-Emam K, McGee S, Ng TL, Savard M-F

Breast Cancer Research and Treatment20252 citations

DOI: 10.1007/s10549-025-07797-1

The Rethinking Clinical Trials (REaCT) Program: A Pragmatic Research Strategy to Improve Cancer Care for Patients, Caregivers, and Healthcare Systems.

Savard MF, Clemons M, McGee SF

Current oncology (Toronto, Ont.)2025First author

DOI: 10.3390/curroncol32090484 PMID: 41002554

Something wrong or missing on this profile? Suggest a correction

Marie-France Savard

Research

Latest papers

Latest funding

Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast Cancer.

Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study

A Randomized Trial Evaluating Personalized Versus Guideline-Based Well Follow-Up Strategies for Patients with Early Breast Cancer: Feasibility Outcomes

HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination With Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer.

Summary of Research: HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer.

Cardiovascular Disease in Males With Breast Cancer: A Population-Based Cohort Study.

Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study

Do regularly scheduled visits result in earlier detection of curable breast cancer recurrences?

Patient perceptions around the use of clinico-pathologic and genomic tools in the management of early breast cancer

The Rethinking Clinical Trials (REaCT) Program: A Pragmatic Research Strategy to Improve Cancer Care for Patients, Caregivers, and Healthcare Systems.

A pragmatic, multicenter randomized study evaluating the benefits and risks of adjuvant endocrine therapy in patients aged 70 years or older with low-risk breast cancer (REaCT-70 Study).

A pragmatic, multicenter randomized study evaluating the benefits and risks of adjuvant endocrine therapy in patients aged 70 years or older with low-risk breast cancer (REaCT-70 Study).

The ESCAPE clinical trial of circulating tumor DNA to guide adjuvant therapy in chemo-resistant triple negative breast cancer

Frequent collaborators

Mark Clemons

Gregory Pond

John Hilton

Khaled El Emam

Brian Hutton

Sharon McGee

Angel Arnaout

Jean-Michel Caudrelier

Sukhbinder Dhesy-Thind

Dean Fergusson

Dhenuka Radhakrishnan

Christina Canil

Melanie Spears

Vasily Giannakeas

Rossanna Pezo

Michael Ong

Eitan Amir

Monica Taljaard

Paul Karanicolas

Stuart Nicholls

Shabbir Alibhai

Paaladinesh Thavendiranathan

Gwen Barton

Muriel Brackstone